Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy. 2019

Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
Department of Neuroscience, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.

Complement pathway overactivation can lead to neuronal damage in various neurological diseases. Although Alzheimer's disease (AD) is characterized by β-amyloid plaques and tau tangles, previous work examining complement has largely focused on amyloidosis models. We find that glial cells show increased expression of classical complement components and the central component C3 in mouse models of amyloidosis (PS2APP) and more extensively tauopathy (TauP301S). Blocking complement function by deleting C3 rescues plaque-associated synapse loss in PS2APP mice and ameliorates neuron loss and brain atrophy in TauP301S mice, improving neurophysiological and behavioral measurements. In addition, C3 protein is elevated in AD patient brains, including at synapses, and levels and processing of C3 are increased in AD patient CSF and correlate with tau. These results demonstrate that complement activation contributes to neurodegeneration caused by tau pathology and suggest that blocking C3 function might be protective in AD and other tauopathies.

UI MeSH Term Description Entries
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009410 Nerve Degeneration Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways. Neuron Degeneration,Degeneration, Nerve,Degeneration, Neuron,Degenerations, Nerve,Degenerations, Neuron,Nerve Degenerations,Neuron Degenerations
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
October 2022, Science advances,
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
April 1998, The Journal of experimental medicine,
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
August 2018, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
November 2014, Neurobiology of disease,
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
January 1994, Pathobiology : journal of immunopathology, molecular and cellular biology,
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
March 2019, Mechanisms of ageing and development,
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
July 2012, Brain : a journal of neurology,
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
January 2002, The Journal of experimental medicine,
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
January 2014, Methods in molecular biology (Clifton, N.J.),
Tiffany Wu, and Borislav Dejanovic, and Vineela D Gandham, and Alvin Gogineni, and Rose Edmonds, and Stephen Schauer, and Karpagam Srinivasan, and Melanie A Huntley, and Yuanyuan Wang, and Tzu-Ming Wang, and Maj Hedehus, and Kai H Barck, and Maya Stark, and Hai Ngu, and Oded Foreman, and William J Meilandt, and Justin Elstrott, and Michael C Chang, and David V Hansen, and Richard A D Carano, and Morgan Sheng, and Jesse E Hanson
October 2018, Molecular therapy : the journal of the American Society of Gene Therapy,
Copied contents to your clipboard!